Danny Lui

Startup Capital Ventures Management Company, LLC (Startup Capital Ventures) is a venture capital firm founded in 2005 by John C. Dean and Danny Lui. The firm is headquartered in Menlo Park, California.

Authosis Ventures (Authosis Ventures) is a venture capital firm founded in 2000 by Danny Lui. The firm is headquartered in Hong Kong.

Zero2IPO Group is a holding company that provides investment and other financial services. It offers research and consulting, event and forum organization, data products, information and news releasing, investment banking services, direct investments, and wealth management. The company was founded by Gavin Ni and Zheng Dong Ni in 1999 and is headquartered in Beijing, China.

Allegis Capital LLC (AllegisCyber Capital) is a venture capital firm founded in 1996 by Robert Ackerman and Barry M Weinman. The firm is headquartered in Palo Alto, California with additional offices in Maryland and Utah.

Dali Wireless, Inc. provides wireless coverage and capacity solutions. Its products include cellular, public safety, and software. It offers all digital distributed antenna system, dynamic capacity allocation, coverage extension, and radio access network virtualization solutions. The company was founded by Leo K. Wong, Albert S. Lee and Dali Yang in 2006 and is headquartered Menlo Park, CA.

BioImagene, Inc. provides innovative digital pathology solutions for the anatomic pathology laboratory. They are in the business of cancer diagnosis and its goal is to make detection, diagnosis, and therapy selection more accurate, efficient, reliable, and accessible. The firm's solutions allow pathologists to collaborate, learn, educate and provide more reliable and consistent diagnoses. Further, its solutions improve the efficiency of laboratory workflow. BioImagene provides digital pathology solutions. Its systems automate pathology workflows for acquisition, analysis, management, archival, reporting, and sharing of tissue images. The firm offers solutions for pathologists, researchers, and drug developers.